Oriahnn: New Drug Approved for Treating Heavy Menstrual Bleeding in Women With Uterine Fibroids - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33998300/
doi: 10.1177/10600280211015987. 1 Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton NY, USA. 2 Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia, PA, USA. doi: 10.1177/10600280211015987. 1 Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton NY, USA. 2 Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia, PA, USA.
Conclusions: Elagolix plus add-back therapy is effective in reducing menstrual bleeding associated with uterine fibroids. However, there are several warnings and precautions that must be considered.